Related Experiment Video
Updated: Aug 2, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Granuloma annulare possibly triggered by antitetanus vaccination
C Baykal1, E Ozkaya-Bayazit, R Kaymaz
1baykalc@istanbul.edu.tr
Journal of the European Academy of Dermatology and Venereology : JEADV
|November 14, 2002
Summary
Granuloma annulare (GA) is a skin condition that may be triggered by antitetanus vaccinations. A rare case shows GA lesions appearing at the vaccination site after an antitetanus shot.
Area of Science:
- Dermatology
- Pediatric Dermatology
- Immunology
Background:
- Granuloma annulare (GA) is a benign inflammatory skin condition characterized by granuloma formation.
- The etiology of GA is largely unknown, but associations with infections, trauma, and vaccinations have been suggested.
- Previous reports have described papular lesions at vaccination sites, but not specifically GA following antitetanus vaccination at the injection site.
Observation:
- A 6-year-old girl experienced multiple episodes of GA.
- The first two episodes occurred independently of vaccination.
- A third episode of GA developed at the site of an antitetanus vaccination, with subsequent lesions appearing on her legs.
Findings:
- This case presents granuloma annulare occurring at the site of an antitetanus vaccination.
- The temporal association and localization suggest a possible link between the vaccination and the localized GA.
- Histopathological findings in similar vaccine-associated lesions suggest necrobiotic granuloma, a feature also seen in GA.
Implications:
- Antitetanus vaccinations may potentially trigger granuloma annulare in susceptible individuals.
- The mechanism could involve local trauma from the injection or a vaccine-induced immune response.
- Further investigation is needed to understand the relationship between vaccinations and granuloma annulare.
Related Concept Videos
Vaccinations
Overview
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Immunological Memory
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

